Does AMISULPRIDE Cause Neurological decompensation? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neurological decompensation have been filed in association with AMISULPRIDE (Barhemsys). This represents 0.2% of all adverse event reports for AMISULPRIDE.
5
Reports of Neurological decompensation with AMISULPRIDE
0.2%
of all AMISULPRIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Neurological decompensation From AMISULPRIDE?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Neurological decompensation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Neurological decompensation?
ALTEPLASE (168)
RITUXIMAB (115)
METHOTREXATE (93)
CYCLOPHOSPHAMIDE (91)
VINCRISTINE (76)
ETOPOSIDE (74)
METHYLPREDNISOLONE (70)
PREDNISONE (70)
DOXORUBICIN (68)
ACETAMINOPHEN (65)
Which AMISULPRIDE Alternatives Have Lower Neurological decompensation Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE